Ultralife (NASDAQ:ULBI) Shares Cross Above 200-Day Moving Average – Time to Sell?
by Doug Wharley · The Cerbat GemUltralife Corporation (NASDAQ:ULBI – Get Free Report) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $6.24 and traded as high as $6.98. Ultralife shares last traded at $6.84, with a volume of 28,351 shares.
Analyst Ratings Changes
Separately, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Ultralife in a report on Monday, December 29th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Ultralife presently has a consensus rating of “Sell”.
Get Our Latest Research Report on ULBI
Ultralife Trading Down 0.7%
The stock’s fifty day simple moving average is $6.28 and its 200-day simple moving average is $6.25. The firm has a market cap of $113.29 million, a PE ratio of -18.89 and a beta of 0.72. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.83 and a quick ratio of 1.39.
Ultralife (NASDAQ:ULBI – Get Free Report) last released its quarterly earnings data on Tuesday, March 10th. The technology company reported $0.12 earnings per share for the quarter, missing analysts’ consensus estimates of $0.24 by ($0.12). The business had revenue of $48.48 million during the quarter, compared to analyst estimates of $57.00 million. Ultralife had a positive return on equity of 3.10% and a negative net margin of 3.09%.
Institutional Trading of Ultralife
A number of hedge funds and other institutional investors have recently made changes to their positions in ULBI. Bank of America Corp DE increased its stake in shares of Ultralife by 30.7% in the fourth quarter. Bank of America Corp DE now owns 12,067 shares of the technology company’s stock worth $90,000 after acquiring an additional 2,836 shares during the period. Jones Financial Companies Lllp increased its stake in shares of Ultralife by 1,428.7% in the first quarter. Jones Financial Companies Lllp now owns 15,287 shares of the technology company’s stock worth $82,000 after acquiring an additional 14,287 shares during the period. Arrowstreet Capital Limited Partnership increased its stake in shares of Ultralife by 474.6% in the second quarter. Arrowstreet Capital Limited Partnership now owns 70,476 shares of the technology company’s stock worth $633,000 after acquiring an additional 58,211 shares during the period. Walleye Capital LLC increased its stake in shares of Ultralife by 127.2% in the second quarter. Walleye Capital LLC now owns 31,102 shares of the technology company’s stock worth $279,000 after acquiring an additional 17,414 shares during the period. Finally, Qube Research & Technologies Ltd acquired a new stake in shares of Ultralife in the second quarter worth $134,000. Institutional investors and hedge funds own 30.68% of the company’s stock.
About Ultralife
Ultralife Corporation (NASDAQ: ULBI) develops, manufactures and sells a broad range of energy and communications products for defense, medical, automotive and consumer electronics markets. The company operates through two primary segments: Power Systems and Communications Systems. In its Power Systems segment, Ultralife produces lithium-ion rechargeable cells and battery packs, primary lithium batteries, alkaline and rechargeable battery packs, chargers and battery accessories designed to meet demanding performance and safety requirements.